Today, Zach Rothstein, Executive Director of AdvaMedDx®, testified before the House Energy and Commerce Committee, Subcommittee on Health during a hearing on diagnostic test regulation and FDA’s proposed laboratory developed…
Today, AdvaMed®, the Medtech Association, released the newest episode of Medtech POV with Scott Whitaker, featuring a conversation with former Senator Richard Burr of North Carolina.
Today, AdvaMedDx® submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx® is a division of AdvaMed® representing companies that develop in…
WASHINGTON, D.C. – Following a Congressional hearing on “Preparing for and Responding to Future Public Health Security Threats,” AdvaMed®, the Medtech Association, released a statement from President and CEO Scott Whitaker echoing the…
Today, AdvaMed®, the medtech association, released the following statement from President and CEO Scott Whitaker on the introduction of the bipartisan Verifying Accurate, Leading-edge IVCT Development (VALID) Act. Introduced in…
AdvaMed®, joined by American Cancer Society Cancer Action Network, The Pew Charitable Trust, Friends of Cancer Research, and other, sent a letter urging the leaders of the Senate Committee on Health,…
The VALID Act is carefully tailored to ensure continued access to tests offered by academic medical centers and other laboratories.
This week, the Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, sent a letter urging House Energy and Commerce and Senate Health, Education, Labor and…
Read a section-by-section breakdown of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021.